Sign In
Buy ALT
$2.87
-0.0300 (-1.03%)
At Close: Jun 03, 2026
Altimmune stock price forecast: brace for more ALT volatility
03:49am, Wednesday, 28'th Feb 2024
Altimmune (NASDAQ: ALT) stock price continued its short squeeze this week, soaring to a high of $14.52, its highest point since February 6th last year. The company's stock surged by more than 580% fro
Why Is Altimmune (ALT) Stock Up 14% Today?
09:26am, Monday, 26'th Feb 2024
Altimmune (NASDAQ: ALT ) stock is rising higher on Monday but it's not actually due to any news from the clinical-stage biopharmaceutical company. Instead, a clinical trial update from rival Zealand P
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024
06:00pm, Thursday, 22'nd Feb 2024
With new innovation, high demand for better treatment, pharmaceutical companies strengthening pipelines and a resurgence of mergers and acquisitions, biotech stocks could offer some of the most explos
Kerrisdale Capital Slams Altimmune (ALT) Stock in New Short Report
03:07pm, Tuesday, 13'th Feb 2024
Kerrisdale Capital is at it again, this time revealing a short position in struggling biotech firm Altimmune (NASDAQ: ALT ). The acclaimed short seller has just released a damning short report on the
Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs
05:31pm, Thursday, 25'th Jan 2024
Everyone knows that America has a major obesity problem. Because of this, new anti-obesity drugs are going to generate a great deal of revenue and profits their companies.
MoneyShow's Best Investment Ideas For 2024: Part 1
09:30am, Thursday, 25'th Jan 2024
MoneyShow presents top investment ideas for 2024 from their contributors. This year's edition presents a broad mix of conservative income stocks, more speculative but potentially more rewarding growth
Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs
06:00am, Thursday, 25'th Jan 2024
Everyone knows that America has a major obesity problem. Because of this, new anti-obesity drugs are going to generate a great deal of revenue and profits their companies.
2 biotechs with promising weight-loss drugs coming
07:01am, Tuesday, 16'th Jan 2024
Clinical weight-loss medications have been making headlines. GLP-1 drugs like Novo Nordisk A/S NYSE: NVO owned Ozempic and Wegovy and Eli Lilly and Co. NYSE: LLY owned Mounjaro and Zepbound contin
Up for 8 straight weeks, is Altimmune (ALT) stock a good buy?
10:56am, Wednesday, 10'th Jan 2024
The Altimmune (NASDAQ: ALT) stock price has been in a strong uptrend in the past few months. It bottomed at $2.07 in October, and the shares have surged by over 475% to its highest level since Februar
The 3 Best Biotech Stocks to Buy in January 2024
11:01pm, Tuesday, 09'th Jan 2024
Biotech is still one of the most exciting investments on the market, creating substantial opportunities for some of the best biotech stocks. Look at obesity drug stocks, like Eli Lilly (NYSE: LLY )
Five obesity-drug trends to watch in 2024: Who can compete with Eli Lilly and Novo Nordisk?
11:17am, Wednesday, 20'th Dec 2023
The obesity drugs that powered huge investor gains in 2023 are poised to inspire more corporate dealmaking, scientific breakthroughs and better patient access in the year ahead, analysts say.
Can Altimmune's weight-loss drug be a game-changer?
07:30am, Thursday, 14'th Dec 2023
The runaway success of weight-loss drugs like Novo Nordisk A/S NYSE: NVO Ozempic and Eli Lilly and Co. NYSE: LLY Mounjaro has kicked off a gold rush for new weight-loss drugs in the medical sector. On
Is Altimmune (ALT) stock a good buy after the 306% jump?
10:37am, Friday, 08'th Dec 2023
Altimmune (NASDAQ: ALT) stock proce has staged a strong recovery in the past few days, making it one of the most popular companies among day traders. The shares jumped to a high of $8.63 on Thursday,
Call Traders Targeting Rallying Weight-Loss Drug Developer
02:05pm, Thursday, 07'th Dec 2023
Options traders are targeting Altimmune Inc (NASDAQ:ALT), as the stock shoots for its 11th-straight win.
Altimmune shares pop as analysts see obesity-drug partnership potential
12:33pm, Thursday, 07'th Dec 2023
Altimmune Inc. shares ALT, +1.02% gained 5% Thursday and have jumped more than 100% this week as analysts see potential for the company to find a partner for its experimental weight-loss drug.
